Popularity #2,725Earnings in 3d
Inventiva (ADR) (IVA)
Developing lanifibranor, an oral MASH candidate, through a pivotal global trial.
$3.55
vs last close−0.10 (−2.87%)
Something off on this page? Send us feedback.
Next report
Sep 25, 26
in 3 days
EPS estimate
−$0.20
Revenue estimate
$6.3M
Fiscal quarter
Q2 FY26
EPSReportedEstimate
Sep '23Mar '24Sep '24Mar '25May '25Sep '25Mar '26Sep '26
Reported−$1.43−$1.25−$1.01−$2.19−$2.69−$1.89−$1.07Pending
Estimate−$1.27−$0.40−$0.56−$0.44−$0.47−$0.41−$0.23−$0.20
Surprise−13.1%−211.7%−81.1%−398.1%−472.9%−361.7%−365.2%—
RevenueReportedEstimate
Sep '23Mar '24Sep '24Mar '25May '25Sep '25Mar '26Sep '26
Reported$7.2M$18.2M$2.9M$11.0M$6.7M$5.2M$2.3MPending
Estimate$1.4M$15.3M—$6.4M$6.4M$8.7M$5.2M$6.3M
Surprise+419.3%+18.9%—+71.2%+4.6%−39.8%−55.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2029 | −$0.46 | — | — |
| Jun 2029 | −$0.45 | — | — |
| Mar 2029 | −$0.29 | — | — |
| Dec 2028 | −$0.39 | — | — |
| Sep 2028 | −$0.36 | — | — |
| Jun 2028 | −$0.55 | — | — |
| Mar 2028 | −$0.54 | — | — |
| Dec 2027 | −$1.16 | — | — |
| Sep 2027 | −$1.15 | — | — |
| Jun 2027 | −$1.11 | — | — |
| Mar 2027 | −$1.10 | — | — |
| Dec 2026 | −$0.50 | — | — |
| Sep 2026 | −$0.79 | — | — |
| Sep 2026 | −$0.20 | — | — |
| Mar 2026 | −$0.79 | — | — |
| Mar 2026 | −$0.23 | −$1.07 | −365.2% |
| Sep 2025 | −$0.41 | −$1.89 | −361.7% |
| May 2025 | −$0.47 | −$2.69 | −472.9% |
| Mar 2025 | −$0.44 | −$2.19 | −398.1% |
| Sep 2024 | |||
| Mar 2024 | |||
| Sep 2023 | |||
| Mar 2023 | |||
| Sep 2022 | |||
| Mar 2022 | |||
| Sep 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| May 2020 | |||
| Dec 2019 | |||
| Jun 2019 | |||
| Dec 2018 | |||
| Jun 2018 | |||
| Dec 2017 | |||
| Jun 2017 | |||
| Dec 2016 | |||
| Jun 2016 | |||
| Dec 2015 | |||
| Jun 2015 | |||
| Jan 2015 | |||
| Jun 2014 | |||
| Jan 2014 | |||
| Jun 2013 | |||
| Jan 2013 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2029 | −$0.46 | — | — | $8.6M | — | — | — |
| Jun 2029 | −$0.45 | — | — | $504.6K | — | — | — |
| Mar 2029 | −$0.29 | — | — | $5.0M | — | — | — |
| Dec 2028 | −$0.39 | — | — | $5.3M | — | — | — |
| Sep 2028 | −$0.36 | — | — | $500.5K | — | — | — |
| Jun 2028 | −$0.55 | — | — | $4.6M | — | — | — |
| Mar 2028 | −$0.54 | — | — | $4.5M | — | — | — |
| Dec 2027 | −$1.16 | — | — | $13.4M | — | — | — |
| Sep 2027 | −$1.15 | — | — | $5.6M | — | — | — |
| Jun 2027 | −$1.11 | — | — | $1.2M | — | — | — |
| Mar 2027 | −$1.10 | — | — | $1.2M | — | — | — |
| Dec 2026 | −$0.50 | — | — | $13.7M | — | — | — |
| Sep 2026 | −$0.79 | — | — | $1.1M | — | — | — |
| Sep 25, 2026 | −$0.20 | — | — | $6.3M | — | — | — |
| Mar 2026 | −$0.79 | — | — | $103.3K | — | — | — |
| Mar 30, 2026 | −$0.23 | −$1.07 | −365.2% | $5.2M | $2.3M | −55.3% | +1.3% |
| Sep 25, 2025 | −$0.41 | −$1.89 | −361.7% | $8.7M | $5.2M | −39.8% | +8.9% |
| May 23, 2025 | −$0.47 | −$2.69 | −472.9% | $6.4M | $6.7M | +4.6% | +8.7% |
| Mar 26, 2025 | −$0.44 | −$2.19 | −398.1% | $6.4M | $11.0M | +71.2% | −2.0% |
| Sep 25, 2024 | |||||||
| Mar 27, 2024 | |||||||
| Sep 28, 2023 | |||||||
| Mar 29, 2023 | |||||||
| Sep 19, 2022 | |||||||
| Mar 3, 2022 | |||||||
| Sep 20, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 16, 2020 | |||||||
| May 14, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Jun 30, 2015 | |||||||
| Jan 31, 2015 | |||||||
| Jun 30, 2014 | |||||||
| Jan 31, 2014 | |||||||
| Jun 30, 2013 | |||||||
| Jan 31, 2013 |